American Association for Cancer Research

SHERPA: Unknown

People

  1. Rosenberg
    Rosenberg
  2. Iyer
    Iyer
  3. Solit
    Solit
  4. Al-Ahmadie
    Al-Ahmadie
  5. Berger
    Berger
  6. Bochner
    Bochner
  7. Bajorin
    Bajorin
  8. Pietzak
    Pietzak
  9. Teo
    Teo
  10. Cha
    Cha

Groups

  1. Department of Medicine (30)
  2. Genitourinary Oncology Service (30)
  3. Solid Tumor Oncology Division (30)
  4. GSK Faculty (21)
  5. Human Oncology and Pathogenesis Program (21)
  6. Department of Pathology and Laboratory Medicine (20)
  7. Center for Molecular Imaging and Biotechnology (CMIB) (17)
  8. Surgery (14)
  9. Urology (14)
  10. Epidemiology and Biostatistics (12)
Search Within
  1. "Jonathan Rosenberg"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (10)
  3. Editorial (2)
Groups
  1. Department of Medicine (30)
  2. Genitourinary Oncology Service (30)
  3. Solid Tumor Oncology Division (30)
  4. GSK Faculty (21)
  5. Human Oncology and Pathogenesis Program (21)
  6. Department of Pathology and Laboratory Medicine (20)

More Groups

People
  1. Jonathan Rosenberg (30)
  2. Gopakumar Iyer (20)
  3. David Solit (19)
  4. Dean Bajorin (18)
  5. Hikmat Al-Ahmadie (18)
  6. Bernard Bochner (14)

More People

Years
  1. 2023 (2)
  2. 2022 (4)
  3. 2021 (3)
  4. 2020 (4)
  5. 2019 (3)
  6. 2018 (2)

More Years

Publications
  1. Clinical Cancer Research (16)
  2. Cancer Research (14)

Results (30)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and genomic landscape of FGFR3-altered urothelial carcinoma and treatment outcomes with erdafitinib: A real-world experience
    Journal Article

    Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Ratna, N.; Duzgol, C.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Regazzi, A. M.; Chen, Z.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Scratching the surface: NECTIN-4 as a surrogate for enfortumab vedotin resistance
    Editorial

    Aggen, D. H.; Chu, C. E.; Rosenberg, J. E.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
    Meeting Abstract

    Chen, Z.; Clinton, T. N.; Park, S.; Lenis, A. T.; Donoghue, M.; Rosenberg, J. E.; Dean, B. F.; Teo, M. Y.; Bochner, B. H.; Ostrovnaya, I.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Identifying potential mechanisms of resistance to erdafitinib (erda) via longitudinal analysis of circulating tumor (ct)-DNA of patients (pts) with advanced/metastatic urothelial cancer
    Meeting Abstract

    Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Ratna, N.; Regazzi, A. M.; Chen, Z.; Lattanzi, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Inactivation mutations of KMT2C/D license a molecular "field effect" and prime the urothelium for tumorigenesis
    Meeting Abstract

    Wang, N.; Pachai, M. R.; Li, D.; Lee, C.; Warda, S.; Xie, G.; Qian, C.; Wong, W. P. E.; Yan, J.; Hu, W.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Inherited germline cancer susceptibility gene variants in individuals with non-muscle-invasive bladder cancer
    Journal Article

    Pietzak, E. J.; Whiting, K.; Srinivasan, P.; Bandlamudi, C.; Khurram, A.; Joseph, V.; Walasek, A.; Bochner, E.; Clinton, T.; Almassi, N.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • NECTIN4 heterogeneity and molecular diversity in bladder cancers: Deconstructing the activity of an antibody-drug conjugate
    Editorial

    Teo, M. Y.; Rosenberg, J. E.
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Identification of a synthetic lethal relationship between nucleotide excision repair deficiency and irofulven sensitivity in urothelial cancer
    Journal Article

    Börcsök, J.; Sztupinszki, Z.; Bekele, R.; Gao, S. P.; Diossy, M.; Samant, A. S.; Dillon, K. M.; Tisza, V.; Spisák, S.; Rusz, O.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Targeting germline- and tumor-associated nucleotide excision repair defects in cancer
    Journal Article

    Topka, S.; Steinsnyder, Z.; Ravichandran, V.; Tkachuk, K.; Kemel, Y.; Bandlamudi, C.; Madsen, M. W.; Furberg, H.; Ouerfelli, O.; Rudin, C. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • The EV-103 Trial: Enfortumab vedotin plus pembrolizumab and/or chemotherapy for patients with locally advanced or metastatic urothelial cancer
    Meeting Abstract

    Hoimes, C. J.; Rosenberg, J. E.; Petrylak, D. P.; Carret, A. S.; Melhem-Bertrandt, A.; Flaig, T. W.
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: